Milstein Howard G MD is categorized under Physicians Offices in La Jolla, CA and active since 1970.
Milstein Howard G MD was established in 1970, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Howard Milstein at the company’s single location by writing to 7334 Girard Avenue # 201, La Jolla, California CA 92037 or by phoning (858) 454-8811. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Milstein Howard G MD |
| Contact Person: | Howard Milstein |
| Address: | 7334 Girard Avenue # 201, La Jolla, California 92037 |
| Phone Number: | (858) 454-8811 |
| Website Address: | drhowardmilstein.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1970 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Milstein Howard G MD was started in 1970 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Howard Milstein for inquiries that concern Milstein Howard G MD by calling the company number (858) 454-8811, as your correspondence is most welcome. Additionally, the physical location of the single location of Milstein Howard G MD can be found at the coordinates 32.83901,-117.27202 as well as the street address 7334 Girard Avenue # 201 in La Jolla, California 92037.
For its online presence, you may visit Milstein Howard G MD’s website at drhowardmilstein.com and engage with its social media outlets through on Twitter and on Facebook.